Sir Charles Gairdner Hospital Revenue and Competitors

AU

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Sir Charles Gairdner Hospital's estimated annual revenue is currently $666.8M per year.(i)
  • Sir Charles Gairdner Hospital's estimated revenue per employee is $378,000

Employee Data

  • Sir Charles Gairdner Hospital has 1764 Employees.(i)
  • Sir Charles Gairdner Hospital grew their employee count by 6% last year.

Sir Charles Gairdner Hospital's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$34.3M127N/AN/AN/A
#2
$34.6M12814%N/AN/A
#3
$49.6M1671%N/AN/A
#4
$15.6M64-9%N/AN/A
#5
$24.6M913%N/AN/A
#6
$81.4M27426%N/AN/A
#7
$31.3M1168%N/AN/A
#8
$55.2M1866%N/AN/A
#9
$48.7M164-4%N/AN/A
#10
$55.8M1886%N/AN/A
Add Company

What Is Sir Charles Gairdner Hospital?

Sir Charles Gairdner Hospital (SCGH) is one of Australia 's leading teaching tertiary hospitals. The Hospital has over 600 beds and employs approximately 5,000 staff who treat over 420,000 patients every year.

keywords:N/A

N/A

Total Funding

1764

Number of Employees

$666.8M

Revenue (est)

6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Sir Charles Gairdner Hospital News

2022-04-17 - Mark McGowan forced into isolation as expert warns against easing COVID restrictions too soon

Sir Charles Gairdner Hospital declared a "code yellow" emergency this ... The number of people in hospital with COVID in WA has hovered in...

2022-04-13 - MJA Podcasts 2022 Episode 15: The changing landscape of ...

Professor Fraser Brims is a consultant respiratory physician at Sir Charles Gairdner Hospital and Director of Early Years Clinical Skills at...

2022-04-13 - Hannah faced a 'deaf future', until an auditory brain stem implant changed her life

In 2019, she underwent surgery at Sir Charles Gairdner Hospital to remove a tumour on the right side of her brain and to insert an auditory...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$668.7M17696%N/A
#2
$445.8M1769N/AN/A
#3
$300M177510%N/A
#4
$879.7M17808%N/A
#5
$566.3M17827%N/A